Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV004719609 | SCV005325215 | uncertain significance | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23217710, 27260575, 31835641, 16752389) |
OMIM | RCV000001765 | SCV000021921 | pathogenic | Autosomal recessive nonsyndromic hearing loss 67 | 2006-07-01 | no assertion criteria provided | literature only | |
Prevention |
RCV003964787 | SCV004783419 | uncertain significance | LHFPL5-related disorder | 2023-12-07 | no assertion criteria provided | clinical testing | The LHFPL5 c.494C>T variant is predicted to result in the amino acid substitution p.Thr165Met. This variant was reported in the homozygous state in six individuals from a consanguineous family with nonsyndromic hearing loss (Kalay. 2006. PubMed ID: 16752389). This variant is reported in 0.0096% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Dr. |
RCV000001765 | SCV005044502 | pathogenic | Autosomal recessive nonsyndromic hearing loss 67 | no assertion criteria provided | clinical testing |